Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ulcerative colitis: conservative management and long-term effects.

Tanja Kühbacher1, Stefan Schreiber, Ulrich R Fölsch

  • 1I. Medizinische Klinik, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany. t.kuehbacher@mucosa.de

Langenbeck'S Archives of Surgery
|May 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geographical patterns of the standing and active human gut microbiome in health and IBD.

Gut·2015
Same author

Validation of a two-step quality control approach for a large-scale human urine metabolomic study conducted in seven experimental batches with LC/QTOF-MS.

Bioanalysis·2015
Same author

Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.

PloS one·2014
Same author

Genetic evidence for PLASMINOGEN as a shared genetic risk factor of coronary artery disease and periodontitis.

Circulation. Cardiovascular genetics·2014
Same author

Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.

Gut·2014
Same author

A large candidate-gene association study suggests genetic variants at IRF5 and PRDM1 to be associated with aggressive periodontitis.

Journal of clinical periodontology·2014
Same journal

Triangular anastomosis enhances early patency of small middle hepatic vein tributaries in right lobe living donor liver transplantation.

Langenbeck's archives of surgery·2026
Same journal

Antibiotic stewardship in non-perforated gangrenous appendicitis: outcomes of single-dose versus postoperative therapy in a retrospective cohort study.

Langenbeck's archives of surgery·2026
Same journal

The role of large language models in the writing of surgical reviews: fact or fantasy?

Langenbeck's archives of surgery·2026
Same journal

Intersphincteric abdominoperineal excision versus low Hartmann's procedure in the robotic era: a single institution experience.

Langenbeck's archives of surgery·2026
Same journal

Management and outcomes in acute symptomatic hernias: a retrospective cohort study and review of cross-over to surgery.

Langenbeck's archives of surgery·2026
Same journal

Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic cancer undergoing neoadjuvant FOLFIRINOX chemotherapy: results from a prospective multicenter trial.

Langenbeck's archives of surgery·2026
See all related articles

Ulcerative colitis involves chronic colon inflammation. Treatment varies by severity, with 5-aminosalicylates for mild cases and advanced therapies for severe or refractory disease.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Immunology

Background:

  • Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon.
  • Symptoms include diarrhea, rectal bleeding, abdominal pain, and fever.
  • The exact cause of ulcerative colitis remains unknown.

Purpose of the Study:

  • To outline current treatment strategies for ulcerative colitis based on disease severity and extent.
  • To review the efficacy of various therapeutic agents for inducing and maintaining remission.

Main Methods:

  • Review of existing literature on ulcerative colitis treatment.
  • Classification of treatments based on disease severity (mild, moderate, severe) and extension (localized, extensive).
  • Categorization of therapies including 5-aminosalicylates, corticosteroids, immunosuppressants, and biological agents.

Related Experiment Videos

Main Results:

  • Topical 5-aminosalicylates are recommended for mild to moderate ulcerative colitis.
  • Oral 5-aminosalicylates are effective for distal colitis and remission maintenance.
  • Corticosteroids are indicated for severe or extensive inflammation, while immunosuppressants are used for chronic or severe cases.
  • Cyclosporine is an option for refractory disease, and proctocolectomy is considered for non-responsive cases.
  • Beta-Interferon shows potential for mild to moderate ulcerative colitis, requiring further investigation.

Conclusions:

  • Treatment selection for ulcerative colitis is guided by disease severity, extent, and response to therapy.
  • A stepwise approach utilizing 5-aminosalicylates, corticosteroids, immunosuppressants, and potentially surgery or biological agents is employed.
  • Ongoing research is necessary to fully establish the role of newer agents like beta-Interferon.